Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15726994 | 0.77 | LMNA (0.33) | — | |
| SCHEMBL27581274 | 0.74 | — | — | |
| SCHEMBL8668525 | 0.73 | DPP4 (0.50) | DPP4THRBCETP | |
| SCHEMBL28498799 | 0.73 | TSHR (0.48) | THRB | |
| SCHEMBL28498800 | 0.73 | THRB (0.48) | THRBCETP | |
| SCHEMBL1148823 | 0.72 | CETP (0.33) | CETP | |
| SCHEMBL2988228 | 0.71 | — | — | |
| SCHEMBL6940066 | 0.71 | — | — | |
| SCHEMBL14152436 | 0.71 | — | — | |
| SCHEMBL2988235 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| WO-2023174773-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2023-09-21 | — | — | WO | disclosed |
| WO-2020236795-A2 | TRISPECIFIC BINDING MOLECULES AGAINST BCMA AND USES THEREOF | NOVARTIS AG (CH) | 2020-11-26 | — | — | WO | disclosed |
| US-10838301-B2 | Resist composition, method of forming resist pattern, fluorine-containing compound, and compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-11-17 | — | — | US | disclosed |
| CN-109983597-A | Organic electroluminescent device | 柯尼卡美能达株式会社 | 2019-07-05 | — | — | CN | disclosed |
| US-20190194365-A1 | COMPOSITION, MODIFICATION METHOD AND SELECTIVE MODIFICATION METHOD OF BASE MATERIAL SURFACE, PATTERN-FORMING METHOD, AND POLYMER | JSR CORPORATION (JP) | 2019-06-27 | — | — | US | disclosed |
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | ROLIC AG (CH) | 2019-02-19 | — | — | US | disclosed |
| CN-109315046-A | The manufacturing method and organic electroluminescent device of organic electroluminescent device | 柯尼卡美能达株式会社 | 2019-02-05 | — | — | CN | disclosed |
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| EP-1966119-A1 | PHOTOCROSSLINKABLE MATERIALS | Rolic AG (CH) | 2008-09-10 | — | — | EP | disclosed |
| EP-1860094-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-11-28 | — | — | EP | disclosed |
| WO-2007098029-A1 | METHODS FOR PREPARING SULFONAMIDE SUBSTITUTED ALCOHOLS AND INTERMEDIATES THEREOF | WYETH (US) | 2007-08-30 | — | — | WO | disclosed |
| WO-2007071091-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2007-06-28 | — | — | WO | disclosed |
| EP-1801097-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-06-27 | — | — | EP | disclosed |
| EP-1303258-B1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2006-10-11 | — | — | EP | disclosed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | disclosed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | disclosed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | DDC, ALAD, DYNC1LI1 | DPP4 871/4885THRB 4854/4885CETP 4221/4885 |
| US-10838301-B2 | Resist composition, method of forming resist pattern, fluorine-containing compound, and compound | AFF1, RER1, AFF2 | DPP4 4869/4885THRB 3699/4885CETP 4416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.